0.00

LOOK FOR STOCKS showing Accelerating Growth
STOCK APPRECIATION will follow Earnings Growth

RISK vs REWARD is a delicate balance
CHOOSE WISELY with our expert guidance

SEBI Registered

We are SEBI Registered Research Analyst (Registration No. INH100001690)

Forbes and ET Recognized

Ekansh Mittal featured in Forbes India’s 2015 edition of Wealth Wizards

Own Investment

We ourselves and our family members invest in the stocks we recommend

Alpha

Multibagger stock recommendations for Long/Medium term

Alpha +

Multibagger stock recommendations + Special Situations

Model Portfolio

Model Portfolio + Multibagger stocks + Special situations

Research Process

In our view, there are no short cuts or rules of thumb. Each company requires a unique research approach and it begins with a careful review of its financial disclosures. We believe a detailed analysis of the disclosure and accounting choices made by management can often provide insight into risks that maybe unknown or underappreciated by the Street. It looks simple in theory. But in practice, it takes good old-fashioned discipline and hard work. We don’t chase hot stock tips,…

Why Choose Us ?

Did you ever realize when your broker/tips provider asked you to trade and guaranteed that you can manage a daily return of 0.5-1% or let’s say 10% per month by trading in cash/futures/options then why does he himself not trade? Did you realize that if he’s so sure about 10% monthly return, why did he himself not get a loan from the bank at 1% monthly interest and traded with the same for 9% effective return and thus pocketed very…

FAQ

What is Katalyst Wealth?  KatalystWealth.com (here in referred to as “Katalyst Wealth”) is the domain owned by Mittal Consulting. We offer independent equity research services to clients on subscription basis. SEBI (Research Analysts) Regulations 2014, Registration No. INH100001690. At Katalyst Wealth we are passionate about sharing our philosophy of value investing, and enabling every individual to become successful investor. Our research is completely objective and Katalyst Wealth is not affiliated with any long or short funds, nor do we accept…

Why do investors make the same mistake again and again?

Dear Sir, Just look at the below equity turnover data and you will know what I am saying. Source:bseindia.com Every time the markets correct in a big way (2008-09, 2011-12, 2018-19), the investor participation goes down substantially. Frankly, it’s painful to see the investors make the same mistake of entering the market at highs and exiting at lows. In fact, I see the same pattern with some of my friends and relatives who were pursuing me aggressively in 2016, 2017…

Read More

Markets have always been cyclical…chose your end wisely

Since ages markets have been volatile and have exhibited cyclicality. Most investors end up on the wrong side of the cycle and thereby lose out on the opportunity of wealth creation and even end up losing principal. Below, we have produced a set of numbers which clearly reflects that you can do well in the stock market if you invest during cyclical downturns. Source: moneycontrol.com What does the above indicate? In the above illustration we have taken values of BSE…

Read More

Look for these warning signs in the stocks of companies you are invested in

Off-late a lot of skeletons are falling out of the closet. In the last few months, we have had stocks of several high growth companies falling off the cliff with investors not getting an opportunity to exit. With the use of technology, while it has become easy to spot companies with high growth and other parameters, it has become all the more important to find how the growth is being funded and whether the reported growth is real or fake.…

Read More

[Report]: Suven Lifesciences (NSE: SUVEN) – A business with lots of optionality

One of our investment theses is to look for businesses with very strong core operations and lots of optionality. By optionality, we mean Low-cost mistakes, with known maximum losses, and large potential payoff. Based on the above theses we initiated a recommendation on Suven Lifesciences (NSE: SUVEN) for our Premium members. The report was initiated around 175 odd levels and in our last update on the company on 16th Feb’19; we had a positive rating around 223 odd levels.  …

Read More
Copy Protected by Chetan's WP-Copyprotect.